Genistein Aglycone Does Not Affect Thyroid Function: Results from a Three-Year, Randomized, Double-Blind, Placebo-Controlled Trial
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Context and Objective: Genistein aglycone positively affects postmenopausal symptoms. However, questions about its long-term safety on the thyroid gland still remain. Design: The parent study was a randomized, double-blind, placebo-controlled trial involving 389 osteopenic, postmenopausal women for 24 months. A subcohort (138 patients) continued therapy for an additional year. Setting: Patients received ambulatory care. Patients and Interventions: Participants received 54 mg of genistein aglycone daily (n = 71) or placebo (n = 67), plus calcium and vitamin D3 at therapeutic doses. Circulating thyroid hormones (TSH, free T3, free T4) and autoantibodies (thyroid peroxidase, thyroglobulin, and thyroid microsomal antigen) were assessed in 40 genistein and 37 placebo subjects who completed 3 yr. Thyroid hormone receptor (THRα and THRβ) and retinoid receptor (RARα, RARγ, and RXRα) expression from peripheral blood monocytes was also evaluated at baseline, 12, 24, and 36 months in all 3-yr completers. Results: Genistein administration over 3 yr did not affect serum thyroid hormones or autoantibodies. In addition, there were no differences in THRα, THRβ, RARα, RARγ, or RXRα mRNA expression between groups. Conclusion: These data suggest that genistein aglycone intake does not significantly increase the risk of clinical or subclinical hypothyroidism at the dose of 54 mg/d.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Messina, M., & Redmond, G. (2006) · Thyroid · doi:10.1089/thy.2006.16.249 · Cited by 200 · cited 3×
“Genistein Aglycone and Thyroid Function J Clin Endocrinol Metab, June 2010, 95(6):3067–3072”
BackgroundInfluentialBreast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
Marini, H., Bitto, A., Altavilla, D., Burnett, B. P., Polito, F., Di Stefano, V., Minutoli, L., Atteritano, M., Levy, R. M., D'Anna, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1087 · Cited by 167 · cited 7×
“In our clinical trial, genistein aglycone positively regulates bone metabolism over 3 yr without harmful estrogenic activity (13, 14) (Fig.”
BackgroundMethodResultSelf-citationThyroid refractoriness in an athyreotic cretin fed soybean formula
Pinchera, A., MacGillivray, M. H., Crawford, J. D., & Freeman, A. G. (1965) · New England Journal of Medicine · doi:10.1056/nejm196507082730205 · Cited by 90 · cited 1×
“to impair levothyroxine absorption in infants (2).”
Cited by
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature
Messina, M. (2016) · Nutrients · doi:10.3390/nu8120754 · Cited by 537
“Studies published since this review [403–407], which include two that were three years in duration [408,409], are supportive of this conclusion as is the conclusion of the EFSA that isoflavone supplements do not affect thyroid function in postmenopausal women [108].”
ResultSoy, Soy Foods and Their Role in Vegetarian Diets
Rizzo, G., & Baroni, L. (2018) · Nutrients · doi:10.3390/nu10010043 · Cited by 498
Petroski, W., & Minich, D. M. (2020) · Nutrients · doi:10.3390/nu12102929 · Cited by 316
Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review
Chen, M.-N., Lin, C.-C., & Liu, C.-F. (2015) · Climacteric · doi:10.3109/13697137.2014.966241 · Cited by 313
Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels
Babić Leko, M., Gunjača, I., Pleić, N., & Zemunik, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126521 · Cited by 264
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Which Sources of Flavonoids: Complex Diets or Dietary Supplements?
Egert, S., & Rimbach, G. (2011) · Advances in Nutrition · doi:10.3945/an.110.000026 · Cited by 212
Risks and benefits of dietary isoflavones for cancer
Andres, S., Abraham, K., Appel, K. E., & Lampen, A. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.541900 · Cited by 168
“Also a 3-year trial with osteopenic postmenopausal women receiving 54 mg genistein aglycones daily did not observe any changes in serum thyroid hormones or antibodies (Bitto et al., 2010).”
BackgroundClinical outcomes of a 2-y soy isoflavone supplementation in menopausal women
Steinberg, F. M., Murray, M. J., Lewis, R. D., Cramer, M. A., Amato, P., Young, R. L., Barnes, S., Konzelmann, K. L., Fischer, J. G., Ellis, K. J., et al. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.008359 · Cited by 79
Systematic review and meta-analysis on the effect of soy on thyroid function
Otun, J., Sahebkar, A., Östlundh, L., Atkin, S. L., & Sathyapalan, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-40647-x · Cited by 68
Sarathi, V., Kolly, A., Chaithanya, H. B., & Dwarakanath, C. S. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0024 · Cited by 14
“A study in postmenopausal women reported that the consumption of isoflavones for three years did not affect the thyroid functions [25].”
Background
Metadata
- Authors
- Bitto, A., Polito, F., Atteritano, M., Altavilla, D., Mazzaferro, S., Marini, H., Adamo, E. B., D'Anna, R., Granese, R., Corrado, F., Russo, S., Minutoli, L., & Squadrito, F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 3067-3072
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2033260715
- Cited by
- 63
- References
- 4
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.